Proliferative pathologic lesions of parathyroid glands encompass a spectrum of entities
ranging from benign hyperplastic processes to malignant neoplasia. This review article …

End-stage renal disease is often complicated by the occurrence of secondary and eventually
tertiary hyperparathyroidism, characterized by increased parathormone, calcium, and …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. Background …

Background Tertiary hyperparathyroidism after kidney transplantation has been associated
with graft dysfunction, cardiovascular morbidity, and osteopenia; however, its true …

Tertiary hyperparathyroidism (HPT III) occurs when an excess of parathyroid hormone (PTH)
is secreted by parathyroid glands, usually after longstanding secondary …

Background Hyperparathyroidism (HPT) is classified into primary HPT (PHPT), secondary
HPT (SHPT), tertiary HPT (THPT), and pseudohyperparathyroidism. Parathyroid surgery is …

Chronic kidney disease mineral and bone disorder may persist after successful kidney
transplantation. Persistent hyperparathyroidism has been identified in up to 80% of patients …

Background. Secondary hyperparathyroidism (SHPT) affects nearly all patients on
maintenance dialysis therapy. SHPT treatment options have considerably evolved over the …

Primary hyperparathyroidism (1° HPT) is a relatively common endocrine disorder usually
caused by autonomous secretion of parathormone by one or several parathyroid adenomas …

Background Hyperparathyroidism is common in patients with chronic kidney disease with
reduced renal function and has been observed after kidney transplantation. The optimal …